RT Journal Article
SR Electronic
T1 Novel risk factors for Coronavirus disease-associated mucormycosis (CAM): a case control study during the outbreak in India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.24.21261040
DO 10.1101/2021.07.24.21261040
A1 Arora, Umang
A1 Priyadarshi, Megha
A1 Katiyar, Varidh
A1 Soneja, Manish
A1 Garg, Prerna
A1 Gupta, Ishan
A1 Bharadiya, Vishwesh
A1 Berry, Parul
A1 Ghosh, Tamoghna
A1 Patel, Lajjaben
A1 Sarda, Radhika
A1 Garg, Shreya
A1 Agarwal, Shubham
A1 Arora, Veronica
A1 Ramprasad, Aishwarya
A1 Kumar, Amit
A1 Garg, Rohit Kumar
A1 Kodan, Parul
A1 Nischal, Neeraj
A1 Singh, Gagandeep
A1 Jorwal, Pankaj
A1 Kumar, Arvind
A1 Baitha, Upendra
A1 Meena, Ved Prakash
A1 Ray, Animesh
A1 Sethi, Prayas
A1 Xess, Immaculata
A1 Vikram, Naval
A1 Sinha, Sanjeev
A1 Biswas, Ashutosh
A1 Thakar, Alok
A1 Bhatnagar, Sushma
A1 Trikha, Anjan
A1 Wig, Naveet
YR 2021
UL http://medrxiv.org/content/early/2021/07/26/2021.07.24.21261040.abstract
AB Background The epidemiology of the Coronavirus-disease associated mucormycosis (CAM) syndemic is poorly elucidated. We aimed to identify risk factors that may explain the burden of cases and help develop preventive strategies.Methods We performed a case-control study comparing cases diagnosed with CAM and those who had recovered from COVID-19 without developing mucormycosis (controls). Information on comorbidities, glycemic control, and practices related to COVID-19 prevention and treatment was recorded.Results 352 patients (152 cases and 200 controls) diagnosed with COVID-19 during April-May 2021 were included. In the CAM group, symptoms of mucormycosis began a mean 18.9 (SD 9.1) days after onset of COVID-19, and predominantly rhino-sinus and orbital involvement was present. All, but one, CAM cases carried conventional risk factors of diabetes and steroid use. On multivariable regression, increased odds of CAM were associated with the presence of diabetes (adjusted OR 3.5, 95%CI 1.1-11), use of systemic steroids (aOR 7.7,95% CI 2.4-24.7), prolonged use of cloth and surgical masks (vs no mask, aOR 6.9, 95%CI 1.5-33.1), and repeated nasopharyngeal swab testing during the COVID-19 illness (aOR 1.6,95% CI 1.2-2.2). Zinc therapy, probably due to its utility in immune function, was found to be protective (aOR 0.05, 95%CI 0.01-0.19). Notably, the requirement of oxygen supplementation or hospitalization did not affect the risk of CAM.Conclusion Judicious use of steroids and stringent glycemic control are vital to preventing mucormycosis. Use of clean masks, preference for N95 masks if available, and minimizing swab testing after the diagnosis of COVID-19 may further reduce the incidence of CAM.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone to declareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institute Ethics Committee of AIIMS, Ansari Nagar, Delhi, India on 28/05/2021. The reference number for the approval is IECPG-353/28.05.21.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon request to the corresponding author, along with a proposed research question explaining the request for data.